Schedule 13G ownership disclosure

GT Biopharma, Inc.

Security class unavailable · CUSIP: 36254L100

Event date: 2024-05-23

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
8.8000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001683168-24-003805
Form type
SC 13G/A
Filer
BRISTOL INVESTMENT FUND LTD
CIK
CIK 1174866
Filed
May 23, 2024
Reporting period
May 23, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub